Neurocrine Bioscience buy Morgan Stanley

Summary

This prediction is currently active. The price of Neurocrine Bioscience has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.92%. This prediction currently runs until 11.11.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Neurocrine Bioscience	-0.885%	-0.885%
iShares Core DAX®	-2.526%	-5.194%
iShares Nasdaq 100	-0.032%	1.561%
iShares Nikkei 225®	-4.202%	-7.550%
iShares S&P 500	-0.802%	0.160%